A M Gillis

Summary

Affiliation: University of Calgary
Country: Canada

Publications

  1. doi request reprint Expert commentary: how well has the call from Heart Rhythm Society/European Heart Rhythm Association for improved device monitoring been answered?
    Anne M Gillis
    Department of Cardiac Sciences, University of Calgary, Libin Cardiovascular Institute of Alberta, 3280 Hospital Drive NW, Calgary, AB, Canada
    Europace 15:i32-i34. 2013
  2. ncbi request reprint Pacing to prevent atrial fibrillation
    A M Gillis
    Department of Pacing and Electrophysiology, Foothills Hospital, Calgary, Alberta, Canada
    Cardiol Clin 18:25-36, vii. 2000
  3. ncbi request reprint Safety and efficacy of advanced atrial pacing therapies for atrial tachyarrhythmias in patients with a new implantable dual chamber cardioverter-defibrillator
    Anne M Gillis
    Foothills Hospital and the division of Cardiology, University of Calgary, 3330 Hospital Drive Northwest, Calgary, Alberta, Canada T2N 4N1
    J Am Coll Cardiol 40:1653-9. 2002
  4. ncbi request reprint Guidelines for implantable cardioverter defibrillator follow-up in Canada: a consensus statement of the Canadian Working Group on Cardiac Pacing
    Anne M Gillis
    Division of Cardiology, University of Calgary, Alberta
    Can J Cardiol 19:21-37. 2003
  5. ncbi request reprint Clinical and electrophysiologic predictors of ventricular tachyarrhythmia recurrence in patients with implantable cardioverter defibrillators
    Anne M Gillis
    Division of Cardiology, Foothills Hospital and Cardiovascular Research Group, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada
    J Cardiovasc Electrophysiol 14:492-8. 2003
  6. ncbi request reprint Redefining physiologic pacing: lessons learned from recent clinical trials
    Anne M Gillis
    Libin Cardiovascular Institute of Alberta and Department of Cardiac Sciences, the University of Calgary and Calgary Health Region, Calgary, Alberta, Canada
    Heart Rhythm 3:1367-72. 2006
  7. ncbi request reprint Reducing unnecessary right ventricular pacing with the managed ventricular pacing mode in patients with sinus node disease and AV block
    Anne M Gillis
    Libin Cardiovascular Institute of Alberta and Department of Cardiovascular Sciences, University of Calgary and Calgary Health Region, Calgary, Alberta, Canada
    Pacing Clin Electrophysiol 29:697-705. 2006
  8. ncbi request reprint Pacing for the prevention of atrial fibrillation
    Anne M Gillis
    University of Calgary, Calgary, Alberta
    Can J Cardiol 21:41B-44B. 2005
  9. ncbi request reprint Clinical trials of pacing for maintenance of sinus rhythm
    Anne M Gillis
    Cardiovascular Research Group, The University of Calgary and Division of Cardiology, Calgary Health Region, Calgary, Alberta, Canada
    J Interv Card Electrophysiol 10:55-62. 2004
  10. ncbi request reprint Selection of pacing mode after interruption of atrioventricular conduction for atrial fibrillation: observations from the PA3 clinical trial
    Anne M Gillis
    Cardiovascular Research Group, The University of Calgary and Division of Cardiology, Calgary Health Region, Calgary, Alberta, Canada
    Card Electrophysiol Rev 7:312-4. 2003

Collaborators

Detail Information

Publications68

  1. doi request reprint Expert commentary: how well has the call from Heart Rhythm Society/European Heart Rhythm Association for improved device monitoring been answered?
    Anne M Gillis
    Department of Cardiac Sciences, University of Calgary, Libin Cardiovascular Institute of Alberta, 3280 Hospital Drive NW, Calgary, AB, Canada
    Europace 15:i32-i34. 2013
    ..This commentary highlights the benefits of remote device monitoring and explores some of the challenges implementation of this technology worldwide...
  2. ncbi request reprint Pacing to prevent atrial fibrillation
    A M Gillis
    Department of Pacing and Electrophysiology, Foothills Hospital, Calgary, Alberta, Canada
    Cardiol Clin 18:25-36, vii. 2000
    ..This article reviews the rationale for atrial pacing as a treatment for AF and the results of recent studies evaluating atrial pacing for prevention of AF...
  3. ncbi request reprint Safety and efficacy of advanced atrial pacing therapies for atrial tachyarrhythmias in patients with a new implantable dual chamber cardioverter-defibrillator
    Anne M Gillis
    Foothills Hospital and the division of Cardiology, University of Calgary, 3330 Hospital Drive Northwest, Calgary, Alberta, Canada T2N 4N1
    J Am Coll Cardiol 40:1653-9. 2002
    ..This study evaluated the safety and efficacy of atrial pacing therapies for the treatment and prevention of atrial tachycardia (AT) or atrial fibrillation (AF) in a new dual chamber implantable cardioverter defibrillator (ICD)...
  4. ncbi request reprint Guidelines for implantable cardioverter defibrillator follow-up in Canada: a consensus statement of the Canadian Working Group on Cardiac Pacing
    Anne M Gillis
    Division of Cardiology, University of Calgary, Alberta
    Can J Cardiol 19:21-37. 2003
    ....
  5. ncbi request reprint Clinical and electrophysiologic predictors of ventricular tachyarrhythmia recurrence in patients with implantable cardioverter defibrillators
    Anne M Gillis
    Division of Cardiology, Foothills Hospital and Cardiovascular Research Group, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada
    J Cardiovasc Electrophysiol 14:492-8. 2003
    ..We evaluated the clinical and electrophysiologic predictors of ventricular tachycardia (VT) and ventricular fibrillation (VF) recurrence following ICD implantation...
  6. ncbi request reprint Redefining physiologic pacing: lessons learned from recent clinical trials
    Anne M Gillis
    Libin Cardiovascular Institute of Alberta and Department of Cardiac Sciences, the University of Calgary and Calgary Health Region, Calgary, Alberta, Canada
    Heart Rhythm 3:1367-72. 2006
  7. ncbi request reprint Reducing unnecessary right ventricular pacing with the managed ventricular pacing mode in patients with sinus node disease and AV block
    Anne M Gillis
    Libin Cardiovascular Institute of Alberta and Department of Cardiovascular Sciences, University of Calgary and Calgary Health Region, Calgary, Alberta, Canada
    Pacing Clin Electrophysiol 29:697-705. 2006
    ..We evaluated a new pacing algorithm, managed ventricular pacing (MVP) which automatically changes modes between AAI/R and DDD/R in patients receiving pacemakers for symptomatic bradycardia...
  8. ncbi request reprint Pacing for the prevention of atrial fibrillation
    Anne M Gillis
    University of Calgary, Calgary, Alberta
    Can J Cardiol 21:41B-44B. 2005
    ..In addition, selective pacing algorithms designed to prevent AF have minimal or no incremental benefits for the prevention of AF. At present, the role of selective atrial lead site(s) for the prevention of AF remains uncertain...
  9. ncbi request reprint Clinical trials of pacing for maintenance of sinus rhythm
    Anne M Gillis
    Cardiovascular Research Group, The University of Calgary and Division of Cardiology, Calgary Health Region, Calgary, Alberta, Canada
    J Interv Card Electrophysiol 10:55-62. 2004
    ..However, there are subsets of patients e.g. those with atrial flutter as well as AF who are likely to benefit from this therapy...
  10. ncbi request reprint Selection of pacing mode after interruption of atrioventricular conduction for atrial fibrillation: observations from the PA3 clinical trial
    Anne M Gillis
    Cardiovascular Research Group, The University of Calgary and Division of Cardiology, Calgary Health Region, Calgary, Alberta, Canada
    Card Electrophysiol Rev 7:312-4. 2003
    ..Given the high probability of permanent AF developing early following ablation, VVIR pacing appears to be the appropriate pacing mode for symptomatic patients undergoing total AV junction ablation...
  11. ncbi request reprint Atrial pacing therapies for prevention of atrial fibrillation in patients with implantable defibrillators
    Anne M Gillis
    Cardiovascular Research Group, The University of Calgary and Division of Cardiology, Calgary Health Region, Calgary, Alberta, Canada
    Card Electrophysiol Rev 7:345-7. 2003
    ..Atrial ATP terminates some episodes of AT but previously reported efficacy rates of 40-50% are exaggerated and in part reflect spontaneous terminations of some AF/AT episodes...
  12. ncbi request reprint Controversies in pacing: indications and programming
    Anne M Gillis
    Faculty of Medicine, University of Calgary, HSC Room 1634, 3330 Hospital Drive NW, Calgary, AB T2N 4N1, Canada
    Curr Cardiol Rep 7:336-41. 2005
    ..Some pacing techniques may be effective in the treatment of sleep apnea but larger, long-term clinical trials are required to demonstrate a significant clinical benefit...
  13. ncbi request reprint Heart block in mice overexpressing calcineurin but not NF-AT3
    Anne M Gillis
    The Cardiovascular Research Group and the Division of Cardiology, The University of Calgary, Health Sciences Hospital 1634, 3330 Hospital Drive NW, Calgary, Alberta, Canada T2N 4N1
    Cardiovasc Res 64:488-95. 2004
    ..We tested the hypothesis that the abnormalities of AV block and propensity to ventricular tachycardia relate to overexpression of calcineurin independent of the development of hypertrophy...
  14. ncbi request reprint High atrial antitachycardia pacing therapy efficacy is associated with a reduction in atrial tachyarrhythmia burden in a subset of patients with sinus node dysfunction and paroxysmal atrial fibrillation
    Anne M Gillis
    Libin Cardiovascular Institute of Alberta and Department of Cardiovascular Sciences, University of Calgary and Calgary Health Region, Calgary, Alberta, Canada
    Heart Rhythm 2:791-6. 2005
    ..We hypothesized that atrial ATP therapy reduces AT/AF burden in a subset of patients with symptomatic bradycardia and frequent paroxysmal AT/AF...
  15. ncbi request reprint Rhythm control in atrial fibrillation: endpoints for device-based trials
    Anne M Gillis
    Cardiovascular Research Group, The University of Calgary, and Division of Cardiology, Calgary Health Region, 3330 Hospital Drive NW, Calgary, Alberta, Canada T2N 4N1
    Heart Rhythm 1:B52-7, discussion B57. 2004
    ..Relevant outcomes might include improvement in symptoms, quality of life, or functional capacity; reduction in hospitalization for cardiovascular causes, stroke death, or overall mortality; or a composite of some of these parameters...
  16. ncbi request reprint Pacing the right ventricle: to pace or not to pace?
    Anne M Gillis
    Libin Cardiovascular Institute and Department of Cardiac Sciences, University of Calgary, Alberta, Canada
    Heart Rhythm 2:201-6. 2005
  17. ncbi request reprint Atrial fibrillation after DDDR pacemaker implantation
    Anne M Gillis
    Cardiovascular Research Group and the Division of Cardiology, The University of Calgary and Foothills Medical Centre, Alberta, Canada
    J Cardiovasc Electrophysiol 13:542-7. 2002
    ..This study evaluated the clinical predictors and time course of AF development in a general pacemaker population...
  18. pmc Treating the right patient at the right time: an innovative approach to the management of atrial fibrillation
    Anne M Gillis
    Libin Cardiovascular Institute of Alberta and Department of Cardiac Sciences, University of Calgary and Calgary Health Region, Calgary, Alberta
    Can J Cardiol 24:195-8. 2008
    ..This experience suggests that a nurse clinician-based AF clinic may provide earlier access to medical care and may improve health outcomes in the long term...
  19. doi request reprint Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management
    Anne M Gillis
    University of Calgary Libin Cardiovascular Institute of Alberta, Calgary, Alberta, Canada
    Can J Cardiol 27:47-59. 2011
    ..Referral for ablation of AF may be considered for patients who remain symptomatic after adequate trials of antiarrhythmic drug therapy and in whom a rhythm control strategy remains desired...
  20. doi request reprint Comparing the 2010 North American and European atrial fibrillation guidelines
    Anne M Gillis
    Department of Cardiac Sciences, University of Calgary and Libin Cardiovascular Institute of Alberta, Calgary, Alberta, Canada
    Can J Cardiol 27:7-13. 2011
    ..The CCS guidelines are the only guidelines at present that recommend dabigitran for prevention of stroke in high risk patients and suggest that dabigatran is preferred to warfarin for stroke prevention in most patient groups...
  21. ncbi request reprint Cardiac pacing in Canada in 1998: working towards optimal pacing therapy. Canadian Working Group on Cardiac Pacing
    A M Gillis
    Division of Cardiology, Foothills Hospital, Calgary, Alberta
    Can J Cardiol 14:1115-20. 1998
    ..Economic constraints, the size of pacing programs and the involvement of committed pacing physicians are factors that may influence the regional differences in cardiac pacing across Canada...
  22. ncbi request reprint Atrial pacing periablation for prevention of paroxysmal atrial fibrillation
    A M Gillis
    Division of Cardiology, The University of Calgary, Calgary, Alberta, Canada
    Circulation 99:2553-8. 1999
    ..This study tested the hypothesis that rate-adaptive atrial pacing would prevent paroxysmal atrial fibrillation (PAF) in patients with frequent PAF in the absence of symptomatic bradycardia...
  23. ncbi request reprint Dispersion of ventricular repolarization and ventricular fibrillation in left ventricular hypertrophy: influence of selective potassium channel blockers
    A M Gillis
    The Cardiovascular Research Group, Departments of Medicine and Pathology, The University of Calgary, Calgary, Alberta, Canada
    J Pharmacol Exp Ther 292:381-6. 2000
    ..05). Thus, combination I(to) and I(Kr) blockers cause greater prolongation APD and increased APD dispersion in left ventricular hypertrophy, and this is associated with the development of ventricular fibrillation...
  24. ncbi request reprint Referring patients for consideration of device treatment of sudden cardiac death and heart failure: incorporating evidence-based therapies within the Canadian health care system
    Anne M Gillis
    Libin Cardiovascular Institute of Alberta, and Department of Cardiac Sciences, University of Calgary and Calgary Health Region, Alberta
    Can J Cardiol 21:25A-30A. 2005
    ....
  25. ncbi request reprint Mechanism of ventricular defibrillation. The role of tissue geometry in the changes in transmembrane potential in patterned myocyte cultures
    A M Gillis
    Department of Physiology, University of Bern, Bern, Switzerland
    Circulation 101:2438-45. 2000
    ..To test this hypothesis, specific nonlinear structures (bifurcations, expansions, and curved strands or "bends") were created in patterned cultures of neonatal rat myocytes...
  26. ncbi request reprint Temporal patterns of paroxysmal atrial fibrillation following DDDR pacemaker implantation
    A M Gillis
    Division of Cardiology, Department of Medicine and Department of Community Health Sciences, Foothills Hospital, Calgary, Alberta, Canada
    Am J Cardiol 85:1445-50. 2000
    ..The temporal patterns of AF change over time after pacemaker implantation. This has implications for the selection of study end points in AF clinical trials...
  27. ncbi request reprint Circadian variation of paroxysmal atrial fibrillation. PA3 Investigators. Atrial Pacing Peri-ablation for Prevention of Atrial Fibrillation Trial
    A M Gillis
    Division of Cardiology, The University of Calgary, Alberta, Canada
    Am J Cardiol 87:794-8, A8. 2001
    ....
  28. doi request reprint Impact of atrial antitachycardia pacing and atrial pace prevention therapies on atrial fibrillation burden over long-term follow-up
    Anne M Gillis
    Health Sciences Centre, Department of Cardiac Sciences, University of Calgary, Calgary Health Region, Rm 1634, 3330 Hospital Dr NW, Calgary, Alberta, Canada
    Europace 11:1041-7. 2009
    ..Accordingly, we compared atrial antitachycardia pacing (ATP) therapy and combined atrial ATP and atrial pace prevention (ATP + Prevention) algorithms to conventional DDD/R pacing for prevention of AT/AF over long-term follow-up...
  29. doi request reprint Beneficial effects of statin therapy for prevention of atrial fibrillation following DDDR pacemaker implantation
    Anne M Gillis
    Department of Cardiac Sciences, Libin Cardiovascular Institute of Alberta, University of Calgary and Calgary Health Region, Calgary, AB, Canada
    Eur Heart J 29:1873-80. 2008
    ..The clinical predictors of at/af recurrence following dual-chamber pacemaker insertion were examined in 185 consecutive patients with paroxysmal AF...
  30. ncbi request reprint Opening Pandora's box: parental anxiety and the assessment of childhood murmurs
    R M Giuffre
    Alberta Children s Hospital, Calgary, Canada
    Can J Cardiol 18:406-14. 2002
    ..Most family physicians and pediatricians recognize the induction of parental anxiety when a newly diagnosed childhood murmur is discussed with a child's parent...
  31. ncbi request reprint Dispersion of ventricular repolarization in left ventricular hypertrophy: influence of afterload and dofetilide
    A M Gillis
    Department of Medicine, The University of Calgary, Alberta, Canada
    J Cardiovasc Electrophysiol 9:988-97. 1998
    ..We compared the effects of increasing afterload and the Class III antiarrhythmic drug, dofetilide, on dispersion of ventricular repolarization in hypertrophied rabbit hearts to normal rabbit hearts...
  32. doi request reprint Effect of metoprolol on quality of life in the Prevention of Syncope Trial
    Robert S Sheldon
    University of Calgary, 3330 Hospital Drive NW, Calgary, Alberta T2N 4N1, Canada
    J Cardiovasc Electrophysiol 20:1083-8. 2009
    ..No therapies have proven useful to improve quality of life in adequately designed randomized clinical trials. Beta-blockers have mixed evidence for effectiveness in preventing syncope...
  33. ncbi request reprint Activation of cardiac tissue by extracellular electrical shocks: formation of 'secondary sources' at intercellular clefts in monolayers of cultured myocytes
    V G Fast
    Department of Physiology, University of Berne, Switzerland
    Circ Res 82:375-85. 1998
    ..These data suggest that small inexcitable obstacles may contribute to the Vm changes during the application of strong extracellular electrical shocks in vivo...
  34. ncbi request reprint Influence of dietary fat on the pharmacodynamics of quinidine, procainamide and tocainide in isolated perfused rabbit hearts
    A M Gillis
    Department of Medicine, University of Calgary, Alberta, Canada
    J Pharmacol Exp Ther 271:176-83. 1994
    ..Thus, dietary fat modulates the effects of the lipophilic drug quinidine on ventricular excitability and repolarization...
  35. ncbi request reprint Paced QT dispersion and QT morphology after radiofrequency atrioventricular junction ablation: impact of left ventricular function
    Satish R Raj
    Division of Cardiology, Foothills Medical Center and the Cardiovascular Disease Research Group, University of Calgary, Calgary, Alberta, Canada
    Pacing Clin Electrophysiol 26:662-8. 2003
    ..02) function groups. Following AVJ ablation, QTdisp increased during a sudden rate drop in patients with reduced LV function, but not in patients with normal LV function...
  36. ncbi request reprint Ventricular high-rate episodes in pacemaker diagnostics identify a high-risk subgroup of patients with tachy-brady syndrome
    Rik Willems
    Department of Cardiac Sciences and Department of Community Medicine, University of Calgary, Alberta, Canada
    Heart Rhythm 1:414-21. 2004
    ..The purpose of this study was to evaluate the frequency and clinical significance of ventricular high-rate (VHR) episodes (ventricular rate >162 bpm) in patients with symptomatic bradycardia and paroxysmal atrial fibrillation (AF)...
  37. ncbi request reprint Noninvasive risk assessment early after a myocardial infarction the REFINE study
    Derek V Exner
    Libin Cardiovascular Institute of Alberta, Calgary, Canada Department of Community Health Sciences, University of Calgary, Calgary, Canada
    J Am Coll Cardiol 50:2275-84. 2007
    ....
  38. doi request reprint Pacemakers, implantable cardioverter/defibrillators, and extracorporeal shockwave lithotripsy: evidence-based guidelines for the modern era
    Michael A Platonov
    Department of Cardiac Sciences, University of Calgary and the Libin Cardiovascular Institute of Alberta, Calgary, Alberta, Canada
    J Endourol 22:243-7. 2008
    ..We review these advances in both technologies as well as the most recent data to construct practice guidelines for the modern era...
  39. pmc Mechanism of hypotensive transients associated with abrupt bradycardias in conscious rabbits
    Robert S Sheldon
    Cardiovascular Research Group, University of Calgary, Alberta
    Can J Cardiol 23:721-6. 2007
    ..Transient bradycardic hypotensive events occur in resting rabbits. If the hypotension is due to vasodepression, these events may be a model for vasovagal syncope...
  40. ncbi request reprint Influence of adenosine A(1)-receptor blockade and vagotomy on the gasping and heart rate response to hypoxia in rats during early postnatal maturation
    James E Fewell
    Department of Physiology and Biophysics, University of Calgary and Libin Cardiovascular Institute of Alberta, Health Sciences Centre, Calgary, Alberta, Canada
    J Appl Physiol (1985) 103:1234-41. 2007
    ....
  41. ncbi request reprint Total atrioventricular nodal ablation increases atrial fibrillation burden in patients with paroxysmal atrial fibrillation despite continuation of antiarrhythmic drug therapy
    Rik Willems
    Division of Cardiology, University of Calgary, AB, Canada
    J Cardiovasc Electrophysiol 14:1296-301. 2003
    ..This usually is ascribed to the cessation of antiarrhythmic drug therapy. We hypothesized that TAVN ablation itself creates an atrial substrate prone to AF...
  42. ncbi request reprint New indications for pacing
    Rik Willems
    Faculty of Medicine, University of Calgary, HSC Room 1634, 3330 Hospital Drive NW, Calgary, AB T2N 4N1, Canada
    Curr Cardiol Rep 5:369-74. 2003
    ..Long-term studies report that it improves quality of life and functional capacity, and reduces hospitalizations for heart failure. The impact of this therapy on mortality awaits the results of ongoing studies...
  43. ncbi request reprint Precordial QT dispersion does not predict inducibility of ventricular tachyarrhythmias at post-revascularization electrophysiologic study
    Satish R Raj
    Division of Cardiology, Foothills Medical Centre and the Cardiovascular Disease Research Group, University of Calgary, 3330 Hospital Drive NW, Calgary, Alberta, Canada, T2N 4N1
    J Interv Card Electrophysiol 6:25-33. 2002
    ..We tested the hypothesis that revascularization would decrease QT interval dispersion and that QT interval dispersion would predict the outcome of the electrophysiologic study following revascularization...
  44. ncbi request reprint Canadian Trial of Physiological Pacing: Effects of physiological pacing during long-term follow-up
    Charles R Kerr
    Room 344, Division of Cardiology, St Paul s Hospital, 1081 Burrard St, Vancouver, BC, Canada, V6Z 1Y6
    Circulation 109:357-62. 2004
    ..However, the occurrence of atrial fibrillation was significantly less frequent with physiological pacemakers. To assess a potential delayed benefit of physiological pacing, follow-up of patients in this study was extended to 6 years...
  45. ncbi request reprint Randomized controlled trial of fixed rate versus rate responsive pacing after radiofrequency atrioventricular junction ablation: quality of life, ventricular refractoriness, and paced QT dispersion
    Henry J Duff
    Cardiovascular Disease Research Group, University of Calgary Health Sciences Centre, HSC 1632, 3330 Hospital Drive NW, Calgary, Alberta, Canada T2N 4N1
    J Cardiovasc Electrophysiol 14:1163-70. 2003
    ..The aim of this study was to provide information about the balance between measures of quality of life versus measures of electrical remodeling achieved by pacing with different rate modalities in a randomized pilot clinical trial...
  46. doi request reprint Canadian Cardiovascular Society atrial fibrillation guidelines 2010: implementing GRADE and achieving consensus
    Anne M Gillis
    Department of Cardiac Sciences, University of Calgary and Libin Cardiovascular Institute of Alberta, Calgary, Alberta, Canada
    Can J Cardiol 27:27-30. 2011
    ..Each recommendation was approved by at least a two-thirds majority of the voting panel (those with a significant conflict recusing themselves from voting on those specific recommendations)...
  47. pmc A novel, simple scale for assessing the symptom severity of atrial fibrillation at the bedside: the CCS-SAF scale
    Paul Dorian
    Division of Cardiology, St Michael s Hospital, University of Toronto, Ontario, Canada
    Can J Cardiol 22:383-6. 2006
    ..Quantifying the effect of AF on patient well-being is important but there is no simple, commonly accepted measure of the effect of AF on quality of life (QoL). Current QoL measures are cumbersome and impractical for clinical use...
  48. ncbi request reprint Are lipid-lowering drugs also antiarrhythmic drugs? An analysis of the Antiarrhythmics versus Implantable Defibrillators (AVID) trial
    L Brent Mitchell
    Division of Cardiology, Foothills Hospital University of Calgary, 1403 29th Street NW, Calgary, Alberta, Canada T2N 2T9
    J Am Coll Cardiol 42:81-7. 2003
    ....
  49. doi request reprint Design and use of a quantitative scale for measuring presyncope
    Robert S Sheldon
    Libin Cardiovascular Institute of Alberta, University of Calgary, Calgary, Alberta, Canada
    J Cardiovasc Electrophysiol 20:888-93. 2009
    ..One important symptom is presyncope, but there are no clinimetric measures of this. We developed the Calgary Presyncope Form (CPF) and used it to test whether metoprolol reduces presyncope in a randomized trial...
  50. ncbi request reprint Conduction time oscillations precede the spontaneous termination of human atrioventricular reciprocating tachycardia
    D V Exner
    Department of Medicine, Division of Cardiology, University of Calgary, Canada
    J Interv Card Electrophysiol 4:231-9. 2000
    ..002. Conduction time oscillations, which are related to apparent enhancement in atrio-His or ventriculoatrial conduction, frequently precede the spontaneous termination of reentry in humans...
  51. ncbi request reprint Ambulatory electrocardiography for the detection of pacemaker lead failure
    A M Gillis
    Pacemaker Clinic, Foothills Hospital, Calgary, Alberta, Canada
    Pacing Clin Electrophysiol 20:1274-82. 1997
    ..AECG is a more sensitive method of surveillance for pacemaker lead function compared to pacemaker clinic assessment. AECG should be incorporated into the routine follow-up of pacemaker patients...
  52. ncbi request reprint Electrosurgery in patients with pacemakers/implanted cardioverter defibrillators
    Jeffrey C Dawes
    Division of Plastic Surgery, Department of Surgery, Foothills Medical Center, Calgary, Alberta, Canada
    Ann Plast Surg 57:33-6. 2006
    ..This article provides surgeons and anesthetists with practical recommendations for use of electrocautery in patients with pacemakers or implantable cardiac defibrillators...
  53. doi request reprint Validation of a new simple scale to measure symptoms in atrial fibrillation: the Canadian Cardiovascular Society Severity in Atrial Fibrillation scale
    Paul Dorian
    Division of Cardiology, St Michael s Hospital, University of Toronto, Toronto, Ontario, Canada
    Circ Arrhythm Electrophysiol 2:218-24. 2009
    ..This study was performed to validate the scale...
  54. ncbi request reprint Antitachycardia pacing therapies and arrhythmia monitoring diagnostics for the treatment of atrial fibrillation
    Anne M Gillis
    Division of Cardiology, University of Calgary and Foothills Hospital, Calgary, Canada
    Can J Cardiol 18:992-5. 2002
    ..The present case also illustrates the value of diagnostic data retrieved from pacemakers for monitoring atrial fibrillation frequency over time and evaluating the efficacy of pacing and drug therapy...
  55. ncbi request reprint The impact of pulse generator longevity on the long-term costs of cardiac pacing
    A M Gillis
    Division of Cardiology, Foothills Hospital, Calgary, Alberta, Canada
    Pacing Clin Electrophysiol 19:1459-68. 1996
    ..Patient survival and pulse generator system longevity should be considered when selecting the appropriate pacing system for the individual patient...
  56. doi request reprint Single diagnostic pacing maneuver for supraventricular tachycardia
    George D Veenhuyzen
    Libin Cardiovascular Institute of Alberta, University of Calgary and Calgary Health Region, Foothills Medical Centre, Calgary, Alberta, Canada
    Heart Rhythm 5:1152-8. 2008
    ..Therefore, diagnosis often requires the integration of multiple pieces of information and/or pacing maneuvers, which adds to the complexity of catheter ablation procedures...
  57. pmc Removal of FKBP12.6 does not alter the conductance and activation of the cardiac ryanodine receptor or the susceptibility to stress-induced ventricular arrhythmias
    Jianmin Xiao
    Libin Cardiovascular Institute of Alberta, Department of Physiology and Biophysics, University of Calgary, Calgary, AB, T2N 4N1, Canada
    J Biol Chem 282:34828-38. 2007
    ..Collectively, our results demonstrate that the loss of FKBP12.6 has no significant effect on the conduction and activation of RyR2 or the propensity for spontaneous Ca(2+) release and stress-induced ventricular arrhythmias...
  58. ncbi request reprint Accuracy of atrial tachyarrhythmia detection in implantable devices with arrhythmia therapies
    Helmut Purerfellner
    St Elisabeth s Sisters Hospital, Linz, Austria
    Pacing Clin Electrophysiol 27:983-92. 2004
    ..7% (80.7-86.3) for AT500 and 92.1% (84.5-96.2) for GEM III AT. Accurate detection and discrimination of FFRWs validates the reliability of AT diagnostic data and decreases the risk of inappropriate device therapy...
  59. pmc The pacemaker and implantable cardioverter defibrillator recall issue - a Canadian perspective
    Christopher S Simpson
    Division of Cardiology, Kingston General Hospital, Queen s University, Ontario
    Can J Cardiol 22:467-71. 2006
    ....
  60. ncbi request reprint I can see clearly now...but at what cost?
    Anne M Gillis
    Heart Rhythm 3:879-80. 2006
  61. ncbi request reprint Effect of surgical revascularization in patients with coronary artery disease and ventricular tachycardia or fibrillation in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Registry
    James R Cook
    Division of Cardiology, Department of Medicine, Baystate Medical Center, Springfield, MA 01199, USA
    Am Heart J 143:821-6. 2002
    ..The magnitude of benefit attributed to revascularization has varied by study, and the use of adjunct implantable cardioverter defibrillator (ICD) therapy has not been well-characterized...
  62. ncbi request reprint Modeling temporial patterns of atrial tachyarrhymias: a new surrogate outcome measure for clinical studies?
    Anne M Gillis
    J Cardiovasc Electrophysiol 13:310-1. 2002
  63. ncbi request reprint Prophylactic implantable cardioverter-defibrillators after myocardial infarction--not for everyone
    Anne M Gillis
    N Engl J Med 351:2540-2. 2004
  64. ncbi request reprint HRS/EHRA expert consensus on the monitoring of cardiovascular implantable electronic devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations
    Bruce L Wilkoff
    Cleveland Clinic, Cleveland, Ohio, USA
    Heart Rhythm 5:907-25. 2008
  65. doi request reprint HRS/EHRA Expert Consensus on the Monitoring of Cardiovascular Implantable Electronic Devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations: developed in partnership with the Heart Rhythm Society (HRS) and
    Bruce L Wilkoff
    Cleveland Clinic, Cleveland, Ohio, USA
    Europace 10:707-25. 2008
  66. ncbi request reprint Tincture of time: when to implant a prophylactic cardioverter-defibrillator following coronary revascularization?
    Anne M Gillis
    J Am Coll Cardiol 47:1818-9. 2006
  67. ncbi request reprint Therapies for the prevention of stroke and other vascular events in atrial fibrillation and atrial flutter
    Stuart J Connolly
    McMaster University, Hamilton, Ontario
    Can J Cardiol 21:71B-73B. 2005
    ..Acetylsalicylic acid is less effective than oral anticoagulants but better tolerated. Anticoagulants are recommended for AF patients with risk factors for stroke...
  68. ncbi request reprint Ambulatory electrocardiographic monitoring to screen for sleep apnea: is it really that simple?
    Anne M Gillis
    J Cardiovasc Electrophysiol 14:474-5. 2003